Activate Immunotherapy Overview
- Year Founded
-
1997

- Status
-
Out of Business
- Employees
-
20

- Latest Deal Type
-
Out of Business
Activate Immunotherapy General Information
Description
Operator of a clinical-stage immuno-oncology platform designed to treat solid tumors. The company's platform utilizes a novel approach for activating the body's immune system to recognize and destroy cancer cells, enabling physicians to treat cancer in their patients effectively.
Contact Information
Website
www.activateimmunotherapy.comCorporate Office
- 8395 Camino Santa Fe Drive
- Suite A
- San Diego, CA 92121
- United States
Corporate Office
- 8395 Camino Santa Fe Drive
- Suite A
- San Diego, CA 92121
- United States
Activate Immunotherapy Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
10. Out of Business | 01-Nov-2019 | Completed | Out of Business | |||
9. Later Stage VC | 15-Aug-2016 | Completed | Generating Revenue | |||
8. Merger/Acquisition | 02-May-2016 | Cancelled | Generating Revenue | |||
7. Later Stage VC (Series C) | 01-Sep-2014 | Completed | Generating Revenue | |||
6. Later Stage VC (Series D) | 14-Mar-2007 | Completed | Generating Revenue | |||
5. Grant | 01-Jan-2007 | Completed | Generating Revenue | |||
4. Later Stage VC (Series B) | 26-Aug-2005 | Completed | Generating Revenue | |||
3. Grant | 12-May-2004 | Completed | Generating Revenue | |||
2. Grant | 01-Jan-2003 | $2.63M | Completed | Generating Revenue | ||
1. Grant | 09-Sep-2002 | $2.95M | Completed | Generating Revenue |
Activate Immunotherapy Patents
Activate Immunotherapy Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20140194429-A1 | Compositions for treatment of cancer | Inactive | 04-Jan-2013 | ||
US-20140194463-A1 | Compositions for treatment of cancer | Inactive | 04-Jan-2013 | ||
US-20140194465-A1 | Compositions for treatment of cancer | Inactive | 04-Jan-2013 | ||
US-20140194478-A1 | Compositions for treatment of cancer | Inactive | 04-Jan-2013 | ||
US-20140194507-A1 | Compositions for treatment of cancer | Inactive | 04-Jan-2013 | C07D307/73 |
Activate Immunotherapy Signals
Activate Immunotherapy FAQs
-
When was Activate Immunotherapy founded?
Activate Immunotherapy was founded in 1997.
-
Where is Activate Immunotherapy headquartered?
Activate Immunotherapy is headquartered in San Diego, CA.
-
What is the size of Activate Immunotherapy?
Activate Immunotherapy has 20 total employees.
-
What industry is Activate Immunotherapy in?
Activate Immunotherapy’s primary industry is Drug Discovery.
-
Is Activate Immunotherapy a private or public company?
Activate Immunotherapy is a Private company.
-
What is Activate Immunotherapy’s current revenue?
The current revenue for Activate Immunotherapy is
. -
How much funding has Activate Immunotherapy raised over time?
Activate Immunotherapy has raised $67.9M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »